PEOPLE - Canada Foundation for Innovation makes appointment:
This article was originally published in Clinica
Executive Summary
Eliot Phillipson has been appointed president and CEO of the Canada Foundation for Innovation (CFI). He succeeds Dr David Strangway, who retires at the end of March, after six years. Dr Phillipson will take up his appointment on July 1; in the interim, senior vice-president Dr Carmen Charette will serve as acting president. Dr Phillipson, a medical doctor with specialist experience in internal medicine, cardiovascular research and respiration, will be responsible for a Can$3.65bn (US$2.79bn) annual budget to "strengthen the capacity of Canadian universities, research hospitals and other non-profit organisations to carry out world-class technology R&D".
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.